Corbus Pharmaceuticals I... (CRBP)
NASDAQ: CRBP
· Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
Pre-market: Aug 18, 2025, 04:00 AM EDT
Corbus Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.2 | -0.95 | -3.77 | -4.5 | -3.47 | -3.87 | -0.83 | -0.74 | -0.95 | -0.43 | -0.32 | -0.58 | -0.32 | -1.5 | -1.88 | -14.67 | -3.11 | -3.57 |
PEG Ratio | -0.33 | -0.01 | 0.12 | 0.07 | -0.08 | -0.11 | 0.04 | -0.07 | 0.02 | -0.01 | -0.01 | 0.01 | -0.00 | -0.18 | -0.01 | 0.17 | -0.46 | -0.09 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 19.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -87.49 | 1.31K | 1.56K | 353.80 |
PB Ratio | 0.76 | 0.51 | 1.01 | 1.65 | 1.11 | 1.10 | -3.87 | 95.86 | 3.52 | 1.85 | 0.42 | 0.49 | 0.64 | 1.09 | 1.12 | 1.65 | 2.77 | 2.50 |
P/FCF Ratio | -5.09 | -3.95 | -13.13 | -17.78 | -15.54 | -13.41 | -4.45 | -4.15 | -4.3 | -2.01 | -0.67 | -2.84 | -2.58 | -6.26 | -7.91 | 149.03 | -12.15 | -10.51 |
P/OCF Ratio | -5.09 | -3.95 | -13.13 | -17.78 | -15.54 | -13.41 | -4.45 | -4.15 | -4.3 | -2.01 | -1.86 | -2.85 | -2.58 | -6.27 | -7.95 | 149.03 | -12.15 | -10.51 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -4.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.00 | 8.81 | -128.36 | -33.67 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.12 | 0.18 | -3.02 | 73.49 | 2.49 | 1.51 | 0.76 | 0.61 | 0.52 | 0.43 | 0.38 | 0.33 | 0.34 | 0.29 |
Quick Ratio | 9.21 | 11.82 | 12.94 | 13.84 | 6.18 | 4.69 | 0.74 | 0.99 | 2.34 | 3.19 | 4.76 | 3.86 | 4.81 | 5.85 | 5.89 | 6.50 | 5.95 | 5.50 |
Current Ratio | 9.21 | 11.82 | 12.94 | 13.84 | 6.18 | 4.69 | 0.74 | 0.99 | 2.34 | 3.19 | 4.76 | 3.86 | 4.81 | 5.85 | 5.89 | 6.51 | 5.96 | 5.52 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | 0.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.01 | 0.00 | 0.00 | 0.00 |
Interest Coverage | n/a | n/a | n/a | -40.7 | -16.85 | -54.36 | -14.29 | -12.43 | -8.12 | n/a | -16.84 | -15.1 | -25.17 | -18.56 | -25.58 | -35.41 | -41.63 | -23.84 |
Return on Equity | -0.16 | -0.13 | -0.07 | -0.09 | -0.08 | -0.07 | 1.16 | -32.32 | -0.92 | -1.08 | -0.33 | -0.21 | -0.5 | -0.18 | -0.15 | -0.03 | -0.22 | -0.18 |
Return on Assets | -0.14 | -0.12 | -0.06 | -0.08 | -0.07 | -0.05 | -0.28 | -0.28 | -0.2 | -0.34 | -0.17 | -0.12 | -0.3 | -0.12 | -0.1 | -0.02 | -0.14 | -0.11 |
Return on Invested Capital | -0.17 | -0.15 | -0.09 | -0.1 | -0.08 | -0.08 | -0.72 | -0.37 | -0.22 | -0.39 | -0.19 | -0.12 | -0.31 | -0.11 | -0.1 | -0.13 | -0.16 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.89 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.27 | -84.44 | -81.49 | -15.55 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -5.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.64 | -22.36 | -125.5 | -24.8 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -5.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.64 | -22.36 | -125.5 | -24.8 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -7.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.34 | -142.57 | -122.3 | -23.79 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | -7.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.77 | -133.71 | -119.48 | -23.15 |